Weekly Clinical Updates

Favorable Antiviral Effect of Metformin on Severe Acute Respiratory Syndrome Coronavirus 2 | Association of Nirmatrelvir–ritonavir with Post-acute Sequelae and Mortality in Patients | Effectiveness of Nirmatrelvir-Ritonavir for the Prevention of COVID-19–Related Hospitalization | Cognitive Profile in Multiple Sclerosis and Post-COVID Condition | Unravelling the Mechanisms Behind Exercise Intolerance and Recovery in Long COVID | Epidemiology of SARS-CoV-2 in Kakuma Refugee Camp Complex, Kenya, 2020-2021

COVID-19 Booster Vaccine Uptake and Reduced Risks for Long-COVID | COVID-19 Immunologic Antiviral Therapy with Omalizumab (CIAO)—a Randomized Controlled Clinical Trial | Abatacept Pharmacokinetics and Exposure Response in Patients | The Gut Microbiome Associates with Phenotypic Manifestations | Characteristics and Determinants of Pulmonary Long COVID | Long COVID: Plasma Levels of Neurofilament Light Chain in Mild COVID-19 Patients with Neurocognitive Symptoms

Durability of Original Monovalent mRNA Vaccine Effectiveness Against COVID-19 Omicron–Associated Hospitalization in Children and Adolescents — United States, 2021–2023 | Remdesivir is Associated with Reduced Mortality in Patients Hospitalized for COVID-19 Not Requiring Supplemental Oxygen | The Persistence of SARS-CoV-2 in Tissues and its Association with Long COVID Symptoms: A Cross-sectional Cohort Study in China

Systematic Analyses of the Factors Influencing Sperm Quality in Patients with SARS-CoV-2 Infection | Nirmatrelvir/ritonavir and Remdesivir against Symptomatic Treatment in High-risk COVID-19 Outpatients to Prevent Hospitalization or Death During the Omicron Era: A Propensity Score-matched Study | Outpatient treatment with concomitant vaccine-boosted convalescent plasma for patients with immunosuppression and COVID-19

Rural-urban Differences in Long-term Mortality and Readmission Following COVID-19 Hospitalization | Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with COVID-19 | Brain and Cognitive Changes in Patients with Long COVID Compared with Infection-recovered Control Subjects | Incident Allergic Diseases in Post-COVID-19 Condition: Multinational Cohort Studies from South Korea, Japan and the UK | Functional Limitations and Exercise Intolerance in Patients with Post-COVID Condition

Interplay of Inflammatory Markers and Anti-SARS-CoV-2 Antibodies in COVID-19 | Association of Premorbid GLP-1RA and SGLT-2i Prescription Alone and in Combination with COVID-19 Severity | Cardiac Adverse Events and Remdesivir in Hospitalized Patients with Coronavirus Disease | Two-Year Longitudinal Study Reveals That Long COVID Symptoms Peak and Quality of Life Nadirs | Paxlovid Use is Associated with Lower Risk of Cardiovascular Diseases in COVID-19 Patients with Autoimmune Rheumatic Diseases